摘要
和肽素(copeptin)是精氨酸加压素前体的羧基肽部分,它在血浆中的变化趋势和精氨酸加压素一致。且具有稳定性好,检测方便等优点,在疾病的临床诊断、预后判断方面有重要价值和优势。这一优势在心血管疾病中逐渐受到重视;和肽素对心力衰竭预后的判断一定程度上优于脑钠肽(BNP)。本文就近年来和肽素在心血管疾病临床应用中的研究进展进行综述。
Copeptin is the carboxyl-peptide part of precursor of arginine vasopressin.It changes consistently with arginine vasopressin.As a stable peptide and conveniently to be detected,copeptin has a lot of advantages in clinical diagnosis and prognostic judgment.Copeptin is better than BNP in prognostic judgment of heart failure.Experts of angiocardiopathy are paying more attention to these advantages.
出处
《大连医科大学学报》
CAS
2010年第3期359-362,共4页
Journal of Dalian Medical University
关键词
和肽素
冠心病
心力衰竭
copeptin
coronary heart disease
heart failure
